Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services to the full chamber. The committee voted 14 to 13 to advance Kennedy in a party-line vote around 10:30 a.m. ET.
Mind Medicine's valuation is surging following Robert F. Kennedy Jr.'s approval as health and human services (HHS) secretary in yesterday's Senate vote. Kennedy has previously voiced support for ...
The Senate has voted to confirm the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Publicly traded ...
Robert F. Kennedy Jr. was confirmed as the new head of the US Department of Health and Human Services, launching a new era in ...
Hosted on MSN24d
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under TrumpShares of Moderna Inc. rose over 5% on Tuesday morning, reaching levels last seen more than a week ago, following news of a $590 million award from the U.S. Health and Human Services ...
Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was named U.S. Health Secretary on Thursday ...
The company said the $590 million grant from the U.S. Department of Health and Human Services was aimed at accelerating development of "mRNA-based pandemic influenza vaccines," including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback